Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

FRA/22UA stock hub

FRA/22UA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/22UAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

20.2B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/22UA

In the news

Latest news · FRA/22UA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 15.7P75 20.2

Trailing P/En/a

P25 16.4P50 20.9P75 30.4

ROE-6.7

P25 -6.7P50 8.5P75 17.2

ROIC-25.6

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/22UA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

185

Groups with data

Currency

EUR

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	7,807
Employees Change	639%
Employees Change Percent	10.42
Enterprise value	EUR 7.1B
Exchange	Frankfurt Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	US09075V1026
Last refreshed	2026-05-10
Market cap	EUR 20.2B
Price	EUR 79.3
Price currency	EUR
Rev Per Employee	359,318.56x
Sector	Healthcare
Sic	2836
Symbol	fra/22UA
Website	https://www.biontech.de

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.19%
EV Earnings	-5.66x
EV/FCF	11.21x
EV/Sales	2.58x
FCF yield	3.13%
P/B ratio	1.08x
P/S ratio	7.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-50.35%
EBITDA Margin	-42.47%
FCF margin	22.55%
Gross margin	78.65%
Gross Profit	EUR 2.2B
Gross Profit Growth	1.19%
Gross Profit Growth Q	-52.83%
Gross Profit Growth3 Y	-40.39%
Gross Profit Growth5 Y	-0.09%
Net Income	EUR -1.3B
Net Income Growth Years	0%
Pretax Margin	-41.83%
Profit Margin	-44.64%
Profit Per Employee	EUR -160,395
ROA	-4.18
Roa5y	27.18
ROCE	-7.31
ROE	-6.66
Roe5y	41.92
ROIC	-25.58
Roic5y	51.46

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-4.4%
Cagr3y	-6.98%
Cagr5y	-11.8%
EPS Growth Years	0
FCF Growth3 Y	-57.97%
OCF Growth3 Y	-54.83%
Revenue Growth	2.15x
Revenue Growth Q	-35.39x
Revenue Growth Years	1x
Revenue Growth3 Y	-38.76x
Revenue Growth5 Y	2.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.13
Assets	EUR 21.1B
Cash	EUR 13.7B
Current Assets	EUR 15.5B
Current Liabilities	EUR 1.8B
Debt	EUR 302.8M
Debt Equity	EUR 0.02
Debt FCF	EUR 0.48
Equity	EUR 18.7B
Interest Coverage	-97.41
Liabilities	EUR 2.4B
Long Term Assets	EUR 5.5B
Long Term Liabilities	EUR 611.3M
Net Cash	EUR 13.4B
Net Cash By Market Cap	EUR 66.28
Net Cash Growth	-0.22%
Net Debt Equity	EUR -0.72
Net Debt FCF	EUR -21.19
Tangible Book Value	EUR 16.8B
Tangible Book Value Per Share	EUR 66.36

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.8
Inventory Turnover	3.34
Net Working Capital	EUR 116.9M
Quick ratio	8.11
Working Capital	EUR 13.8B
Working Capital Turnover	EUR 0.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.91%
Dividend per share	EUR 0
Last Dividend	EUR 1.45

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-4.4%
200-day SMA	87.88
3Y total return	-19.51%
50-day SMA	82.95
50-day SMA vs 200-day SMA	50under200
5Y total return	-46.62%
All Time High	396.9
All Time High Change	-80.02%
All Time High Date	2021-08-10
All Time Low	11.5
All Time Low Change	589.57%
All Time Low Date	2019-10-15
ATR	3.7
Ch YTD	-3
High	80.25
High52	111.6
High52 Date	2025-06-03
High52ch	-28.94%
Low	77.4
Low52	68
Low52 Date	2026-03-10
Low52ch	16.62%
Ma50ch	-4.39%
Price vs 200-day SMA	-9.76%
RSI	40.25
RSI Monthly	43.93
RSI Weekly	44.06
Sharpe ratio	0.07x
Sortino ratio	0.21
Total Return	-1.91%
Tr YTD	-3
Tr1m	1.73%
Tr1w	-8.06%
Tr3m	-12.08%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -1.4B
Operating margin	-50.35

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	109,300,437%
Net Borrowing	-10,700,000
Shares Insiders	16.73%
Shares Institutions	20.1%
Shares Qo Q	3.81%
Shares Yo Y	1.91%
Short Ratio	2.86

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 549.6M
Average Volume	1,710x
Bv Per Share	73.94
CAPEX	EUR -183M
Ch1m	1.73
Ch1w	-8.06
Ch1y	-4.4
Ch3m	-12.08
Ch3y	-19.51
Ch5y	-47.13
Ch6m	-8.85
Change	-1%
Change From Open	0.83
Close	80.1
Days Gap	-1.81
Depreciation Amortization	221,100,000
Dollar Volume	45,518.2
Earnings Date	2026-05-05
EBIT	EUR -1.4B
EBITDA	EUR -1.2B
EPS	EUR -5.11
F Score	3
FCF	EUR 632.7M
FCF EV Yield	8.92x
Financing CF	-12,700,000
Fiscal Year End	December
Founded	2,008
Goodwill	370,500,000
Income Tax	EUR 78.7M
Investing CF	-1,064,700,000
Is Primary Listing	0
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Ma150	86.99
Ma150ch	-8.84%
Ma20	85.77
Ma20ch	-7.54%
Net CF	-245,500,000
Next Earnings Date	2026-08-04
Open	78.65
P FCF Ratio	31.96
P OCF Ratio	24.79
Position In Range	66.67
Ppne	1,318,200,000
Price Date	2026-05-08
Ptbv Ratio	1.21
Relative Volume	0.34x
Revenue	2,805,200,000x
SBC By Revenue	2.96x
Share Based Comp	83,100,000
Tax By Revenue	2.81x
Tr6m	-8.85%
Volume	574
Z Score	7.3

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/22UA pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/22UA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/22UA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+20.1%

Share of float held by funds and institutions

Insider ownership

+16.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/22UA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.2

Neutral momentum band

Price vs 200-day MA

-9.8%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.07

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/22UA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/22UA stock rating?

fra/22UA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/22UA analysis?

The full report lives at /stocks/fra/22UA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/22UA?

The latest report frames fra/22UA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/22UA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.